Home > Press > Arrowhead Presents New Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at AHA Scientific Sessions 2019Abstract:Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented updated Phase 1 clinical data on its two RNAi-based cardiometabolic candidates, ARO-APOC3 targeting apolipoprotein C-III (APOC3) being developed as a potential treatment for patients...
Old newspapers can be used to grow carbon nanotubes
Nov 22, 2019 (Nanowerk News) A research collaboration between Rice University and the Energy Safety Research Institute (ESRI) at Swansea University has found that old newspapers can be used as a low cost, eco-friendly material on which to grow single-walled carbon nanotubes on a large scale. Carbon nanotubes are tiny...